Information about Progress Clinical Research Holding
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

Progress Clinical Research Holding (SRL)

81277938

Cronenburg 75, 1081 GM Amsterdam

Company information

Status
Active

KVK number

81277938

VAT Number

Established
24-12-2020
Last balance sheet year
2022
Company size
Small 0 FTE
RSIN number
862038145
Commercial name
Progress Clinical Research
Principal activity
Activiteiten van financieringsentiteiten binnen concernverband
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Progress Clinical Research Holding

2022 2021 2020
Equity € 295.781 10 % € 269.280 538460 % € 50
Employees 0 0 0

Frequently asked questions

What is the VAT number of Progress Clinical Research Holding?
Log in or start a free trial to view the VAT number.
What is the KVK number of Progress Clinical Research Holding?
The KVK number of Progress Clinical Research Holding is 81277938
When was Progress Clinical Research Holding founded?
Progress Clinical Research Holding was founded on 24-12-2020.
What is the address of Progress Clinical Research Holding?
The current registered office of Progress Clinical Research Holding is located at Cronenburg 75, 1081 GM Amsterdam.
When was the last time Progress Clinical Research Holding filed their annual financial statements?
The most recent financial statements of Progress Clinical Research Holding were filed on 12-12-2023.
How many employees does Progress Clinical Research Holding have?
There are currently no employees working at Progress Clinical Research Holding or no workforce information is available.
What is the annual turnover of Progress Clinical Research Holding?
There is no turnover available for Progress Clinical Research Holding.

Sources